# FDA Inspection 1195102 - HNM Medical - January 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/hnm-medical/85fd3591-9b56-40b5-a1d1-ae7501e29489
Source feed: FDA_Inspections

> FDA Inspection 1195102 for HNM Medical on January 11, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195102
- Company Name: HNM Medical
- Inspection Date: 2023-01-11
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1195102 - 2023-01-11](https://www.keypedia.com/records/fda_inspections/hnm-medical/5e140721-0eb3-4054-806d-849688ff881b)
- [FDA Inspection 1051266 - 2018-05-09](https://www.keypedia.com/records/fda_inspections/hnm-medical/1a9638c3-96b1-4dab-89f4-9ae8117ca7d7)
- [FDA Inspection 1051266 - 2018-05-09](https://www.keypedia.com/records/fda_inspections/hnm-medical/77ce8e2e-cd4d-4bd7-9c4a-c9d9c13d0538)
- [FDA Inspection 987024 - 2016-09-02](https://www.keypedia.com/records/fda_inspections/hnm-medical/a25c14db-91b8-449a-89c7-8eb89557e9cd)

Company: https://www.keypedia.com/companies/hnm-medical/05d21fab-8dea-4f27-b882-e6d9b3bbdb24

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
